ITTO20050301A1 - Formulazioni liquide orali contenenti citalopram - Google Patents

Formulazioni liquide orali contenenti citalopram

Info

Publication number
ITTO20050301A1
ITTO20050301A1 IT000301A ITTO20050301A ITTO20050301A1 IT TO20050301 A1 ITTO20050301 A1 IT TO20050301A1 IT 000301 A IT000301 A IT 000301A IT TO20050301 A ITTO20050301 A IT TO20050301A IT TO20050301 A1 ITTO20050301 A1 IT TO20050301A1
Authority
IT
Italy
Prior art keywords
oral liquid
formulations containing
liquid formulations
containing citalopram
citalopram
Prior art date
Application number
IT000301A
Other languages
English (en)
Inventor
Sandra Tavazzi
Original Assignee
Errekappa Euroterapici Spa
Medi Service Srl
Pharmacare Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Euroterapici Spa, Medi Service Srl, Pharmacare Srl filed Critical Errekappa Euroterapici Spa
Priority to IT000301A priority Critical patent/ITTO20050301A1/it
Priority to ES05017678T priority patent/ES2311187T3/es
Priority to AT05017678T priority patent/ATE401864T1/de
Priority to EP05017678A priority patent/EP1726298B1/en
Priority to DE602005008398T priority patent/DE602005008398D1/de
Publication of ITTO20050301A1 publication Critical patent/ITTO20050301A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000301A 2005-05-05 2005-05-05 Formulazioni liquide orali contenenti citalopram ITTO20050301A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000301A ITTO20050301A1 (it) 2005-05-05 2005-05-05 Formulazioni liquide orali contenenti citalopram
ES05017678T ES2311187T3 (es) 2005-05-05 2005-08-12 Formulaciones liquidas orales que contienen citalopram.
AT05017678T ATE401864T1 (de) 2005-05-05 2005-08-12 Orale flüssige citalopram enthaltende formulierungen
EP05017678A EP1726298B1 (en) 2005-05-05 2005-08-12 Oral liquid formulations containing citalopram
DE602005008398T DE602005008398D1 (de) 2005-05-05 2005-08-12 Orale flüssige Citalopram enthaltende Formulierungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000301A ITTO20050301A1 (it) 2005-05-05 2005-05-05 Formulazioni liquide orali contenenti citalopram

Publications (1)

Publication Number Publication Date
ITTO20050301A1 true ITTO20050301A1 (it) 2006-11-06

Family

ID=37085321

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000301A ITTO20050301A1 (it) 2005-05-05 2005-05-05 Formulazioni liquide orali contenenti citalopram

Country Status (5)

Country Link
EP (1) EP1726298B1 (it)
AT (1) ATE401864T1 (it)
DE (1) DE602005008398D1 (it)
ES (1) ES2311187T3 (it)
IT (1) ITTO20050301A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102415992A (zh) * 2011-11-24 2012-04-18 福格森（武汉）生物科技有限公司 依他普仑口服液体制剂
ITMI20120105A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Soluzione acquosa di escitalopram ossalato e relativo utilizzo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
EP1631274A4 (en) * 2003-05-27 2007-03-28 Forest Laboratories COMBINATION OF A NMDA RECEPTOR ANTAGONIST AND A SELECTIVE SEROTONINE RECOURSE HEMMER FOR TREATING DEPRESSIONS AND OTHER MUTUAL DISORDERS

Also Published As

Publication number Publication date
EP1726298A2 (en) 2006-11-29
DE602005008398D1 (de) 2008-09-04
ES2311187T3 (es) 2009-02-01
EP1726298A3 (en) 2007-05-09
EP1726298B1 (en) 2008-07-23
ATE401864T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
ATE403425T1 (de) Feste formulierungen enthaltend eine indolinon verbindung
IL162118A0 (en) Pharmaceutical compositions containing an orally active taxane derivative
NO20033556L (no) Farmasöytiske formuleringer
PL363215A1 (pl) Kompozycja farmaceutyczna o zmniejszonej tendencji do krystalizacji leku
ITTO20010005A1 (it) Formulazione farmaceutica.
BRPI0620229A8 (pt) formulação
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
MX260260B (es) Formulaciones semi-solidas para la administracion oral de taxoides.
NO20054214D0 (no) Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
ITTO20050301A1 (it) Formulazioni liquide orali contenenti citalopram
ITFI20020144A1 (it) Formulazioni topiche stabilizzate contenenti ketoprofene.
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
NL1025908A1 (nl) Farmaceutische combinatie.
FR2890312B1 (fr) Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant
MXPA03001857A (es) Composicones medicinales.